Evidence map›Paper›PMID 25748550›Full record

ArticleToxicology2015

Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related.

Kevin M Beggs, Ashley R Maiuri, Aaron M Fullerton, Kyle L Poulsen, Anna B Breier, Patricia E Ganey, Robert A Roth

Open access · greenAbstract read
In one paragraph

Article in Toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. HIVIL: A humanNAM journal · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic Cells.Toxicological sciences : an official journal of the Society of Toxicology · 2016
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kevin M BeggsMichigan State University, Department of Pharmacology & Toxicology, Center for Integrative Toxicology, 1129 Farm Lane, East Lansing, MI 48824, United States.
Ashley R MaiuriMichigan State University, Department of Pharmacology & Toxicology, Center for Integrative Toxicology, 1129 Farm Lane, East Lansing, MI 48824, United States.
Aaron M FullertonMichigan State University, Department of Pharmacology & Toxicology, Center for Integrative Toxicology, 1129 Farm Lane, East Lansing, MI 48824, United States.
Kyle L PoulsenMichigan State University, Department of Pharmacology & Toxicology, Center for Integrative Toxicology, 1129 Farm Lane, East Lansing, MI 48824, United States.
Anna B BreierMichigan State University, Department of Pharmacology & Toxicology, Center for Integrative Toxicology, 1129 Farm Lane, East Lansing, MI 48824, United States.
Patricia E GaneyMichigan State University, Department of Pharmacology & Toxicology, Center for Integrative Toxicology, 1129 Farm Lane, East Lansing, MI 48824, United States.
Robert A RothMichigan State University, Department of Pharmacology & Toxicology, Center for Integrative Toxicology, 1129 Farm Lane, East Lansing, MI 48824, United States. Electronic address: rothr@msu.edu.
Michigan State University · US

Funding

INFLAMMATION AND DRUG IDIOSYNCRASYR01DK061315 · NIDDK · MICHIGAN STATE UNIVERSITY · PI ROTH, ROBERT ANDREW · 2003 to 2011
$2.0M
Integrative Training in the Pharmacological SciencesT32GM092715 · NIGMS · MICHIGAN STATE UNIVERSITY · PI NEUBIG, RICHARD R · 2011 to 2020
$1.5M
NIDDK NIH HHS R01 DK061315NIDDK NIH HHS R01DK061315NIGMS NIH HHS T32 GM092715
6 · The paper itself

Abstract

Use of the fluoroquinolone antibiotic trovafloxacin (TVX) was restricted due to idiosyncratic, drug-induced liver injury (IDILI). Previous studies demonstrated that tumor necrosis factor-alpha (TNF) and TVX interact to cause death of hepatocytes in vitro that was associated with prolonged activation of c-Jun N-terminal kinase (JNK), activation of caspases 9 and 3, and DNA damage. The purpose of this study was to explore further the mechanism by which TVX interacts with TNF to cause cytotoxicity. Treatment with TVX caused cell cycle arrest, enhanced expression of p21 and impaired proliferation, but cell death only occurred after cotreatment with TVX and TNF. Cell death involved activation of extracellular signal-related kinase (ERK), which in turn activated caspase 3 and ataxia telangiectasia and Rad3-related (ATR), both of which contributed to cytotoxicity. Cotreatment of HepG2 cells with TVX and TNF caused double-strand breaks in DNA, and ERK contributed to this effect. Inhibition of caspase activity abolished the DNA strand breaks. The data suggest a complex interaction of TVX and TNF in which TVX causes replication stress, and the downstream effects are exacerbated by TNF, leading to hepatocellular death. These results raise the possibility that IDILI from TVX results from MAPK and ATR activation in hepatocytes initiated by interaction of cytokine signaling with drug-induced replication stress.

Indexed as

Anti-Bacterial AgentsAtaxia Telangiectasia Mutated ProteinsCaspase 3Cell Cycle CheckpointsCell ProliferationChemical and Drug Induced Liver InjuryCyclin-Dependent Kinase Inhibitor p21DNA Breaks, Double-StrandedDNA ReplicationEnzyme ActivationExtracellular Signal-Regulated MAP KinasesFluoroquinolonesHepatocytesHep G2 CellsHumansLiverAnti-Bacterial AgentsAtaxia Telangiectasia Mutated ProteinsATR protein, humanCASP3 protein, humanCaspase 3CDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Extracellular Signal-Regulated MAP KinasesFluoroquinolonesNaphthyridinesProtein Kinase InhibitorsTP53 protein, humantrovafloxacinTumor Necrosis Factor-alphaTumor Suppressor Protein p53ATRERKHepatotoxicityIdiosyncratic drug-induced liver injuryTNFTrovafloxacin

Identifiers

PMID25748550
PMCPMC4445241
OpenAlexW2028348804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.